Skip to content
20-F

Annual Report (Foreign)

CytoMed Therapeutics Ltd GDTC

0001493152-26-013813

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 11.65M sh
Shares Diluted FY 2025 · Dec 31, 2024 11.54M sh
Shares Diluted FY 2025 · Dec 31, 2023 10.63M sh
Shares Outstanding FY 2025 · Dec 31, 2025 11.83M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$2.88M
Operating Cash Flow FY 2025 · Dec 31, 2025 −3.7M
Operating Cash Flow FY 2025 · Dec 31, 2024 −2.71M
Operating Cash Flow restated FY 2025 · Dec 31, 2023 −3.53M
Cash And Equivalents FY 2025 · Dec 31, 2025 $1.63M
Cash And Equivalents FY 2025 · Dec 31, 2025 2.1M
Cash And Equivalents restated FY 2025 · Dec 31, 2024 $3.65M
Cash And Equivalents FY 2025 · Dec 31, 2024 4.7M
Cash And Equivalents FY 2025 · Dec 31, 2023 6.22M
Cash And Equivalents FY 2025 · Dec 31, 2022 1.58M
Stockholders Equity FY 2025 · Dec 31, 2025 $5.33M
Stockholders Equity FY 2025 · Dec 31, 2025 6.85M
Stockholders Equity FY 2025 · Dec 31, 2024 9.04M
Stockholders Equity FY 2025 · Dec 31, 2023 11.24M
Stockholders Equity FY 2025 · Dec 31, 2022 586.3K
Current Liabilities FY 2025 · Dec 31, 2025 $551.5K
Current Liabilities FY 2025 · Dec 31, 2025 709.17K
Current Liabilities FY 2025 · Dec 31, 2024 606.62K
Total Liabilities FY 2025 · Dec 31, 2025 $879.76K
Total Liabilities FY 2025 · Dec 31, 2025 1.13M
Total Liabilities FY 2025 · Dec 31, 2024 1.02M
Current Assets FY 2025 · Dec 31, 2025 $2.85M
Current Assets FY 2025 · Dec 31, 2025 3.66M
Current Assets FY 2025 · Dec 31, 2024 6M
Total Assets FY 2025 · Dec 31, 2025 $6.21M
Total Assets FY 2025 · Dec 31, 2025 7.98M
Total Assets FY 2025 · Dec 31, 2024 10.07M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.27
Eps Diluted FY 2025 · Dec 31, 2025 −0.34
Eps Diluted FY 2025 · Dec 31, 2024 −0.22
Eps Diluted FY 2025 · Dec 31, 2023 −0.39
Eps Basic FY 2025 · Dec 31, 2025 −$0.27
Eps Basic FY 2025 · Dec 31, 2025 −0.34
Eps Basic FY 2025 · Dec 31, 2024 −0.22
Eps Basic FY 2025 · Dec 31, 2023 −0.39
Rd Expense FY 2025 · Dec 31, 2025 $1.72M
Rd Expense FY 2025 · Dec 31, 2025 2.22M
Rd Expense FY 2025 · Dec 31, 2024 1.91M
Rd Expense FY 2025 · Dec 31, 2023 1.59M
Net Income FY 2025 · Dec 31, 2025 −$3.11M
Net Income FY 2025 · Dec 31, 2025 −4M
Net Income FY 2025 · Dec 31, 2024 −2.52M
Net Income FY 2025 · Dec 31, 2023 −4.13M
Revenue FY 2025 · Dec 31, 2025 $252.27K
Revenue FY 2025 · Dec 31, 2025 324.39K
Revenue FY 2025 · Dec 31, 2024 69.5K